Jerzy Boryski

955 total citations
65 papers, 803 citations indexed

About

Jerzy Boryski is a scholar working on Molecular Biology, Organic Chemistry and Infectious Diseases. According to data from OpenAlex, Jerzy Boryski has authored 65 papers receiving a total of 803 indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Molecular Biology, 39 papers in Organic Chemistry and 22 papers in Infectious Diseases. Recurrent topics in Jerzy Boryski's work include HIV/AIDS drug development and treatment (22 papers), Biochemical and Molecular Research (21 papers) and Carbohydrate Chemistry and Synthesis (17 papers). Jerzy Boryski is often cited by papers focused on HIV/AIDS drug development and treatment (22 papers), Biochemical and Molecular Research (21 papers) and Carbohydrate Chemistry and Synthesis (17 papers). Jerzy Boryski collaborates with scholars based in Poland, Japan and Belgium. Jerzy Boryski's co-authors include Bożenna Golankiewicz, Erik De Clercq, Grzegorz Framski, Grzegorz Grynkiewicz, Adam Kraszewski, Jacek Stawiński, Tohru Ueda, Daniel Baranowski, Janusz Skierski and Roberta Loddo and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Chromatography A and Tetrahedron.

In The Last Decade

Jerzy Boryski

62 papers receiving 787 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jerzy Boryski Poland 17 463 400 196 134 44 65 803
Lenka Poštová Slavětínská Czechia 18 435 0.9× 418 1.0× 224 1.1× 144 1.1× 38 0.9× 71 891
Elmer J. Reist United States 20 724 1.6× 743 1.9× 176 0.9× 125 0.9× 62 1.4× 87 1.3k
K. Raja Reddy United States 17 483 1.0× 472 1.2× 219 1.1× 161 1.2× 60 1.4× 26 1.1k
Kazuo Sakane Japan 16 318 0.7× 485 1.2× 257 1.3× 171 1.3× 49 1.1× 66 975
Argyrides Argyrou United States 19 733 1.6× 151 0.4× 297 1.5× 154 1.1× 45 1.0× 30 1.0k
Tasneem A. Khwaja United States 15 458 1.0× 228 0.6× 95 0.5× 98 0.7× 127 2.9× 46 780
Konrad Misiura Poland 16 390 0.8× 381 1.0× 65 0.3× 24 0.2× 75 1.7× 67 817
Woo‐Baeg Choi United States 12 247 0.5× 288 0.7× 208 1.1× 77 0.6× 23 0.5× 20 564
Ernest J. Prisbe United States 14 459 1.0× 435 1.1× 308 1.6× 176 1.3× 15 0.3× 21 814
Sheng Tang China 17 379 0.8× 237 0.6× 71 0.4× 90 0.7× 69 1.6× 43 752

Countries citing papers authored by Jerzy Boryski

Since Specialization
Citations

This map shows the geographic impact of Jerzy Boryski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jerzy Boryski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jerzy Boryski more than expected).

Fields of papers citing papers by Jerzy Boryski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jerzy Boryski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jerzy Boryski. The network helps show where Jerzy Boryski may publish in the future.

Co-authorship network of co-authors of Jerzy Boryski

This figure shows the co-authorship network connecting the top 25 collaborators of Jerzy Boryski. A scholar is included among the top collaborators of Jerzy Boryski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jerzy Boryski. Jerzy Boryski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Baranowski, Daniel, Jerzy Boryski, & Tomasz Ostrowski. (2021). 7-(β-d-Ribofuranosyl)-3-methylguanine: Synthesis from guanine and comparative multinuclear NMR studies. Journal of Molecular Structure. 1250. 131911–131911.
2.
Ruszkowski, Piotr, et al.. (2019). Nucleoside dimers analogs containing floxuridine and thymidine with unnatural linker groups: synthesis and cancer line studies. Part III. Nucleosides Nucleotides & Nucleic Acids. 38(12). 980–1005. 8 indexed citations
3.
Sobkowski, Michał, et al.. (2018). Aryl H-phosphonates. 19. New anti-HIV pronucleotide phosphoramidate diesters containing amino- and hydroxypyridine auxiliaries. European Journal of Medicinal Chemistry. 164. 47–58. 9 indexed citations
4.
Lisowiec‐Wąchnicka, Jolanta, et al.. (2017). Thermodynamic, structural and fluorescent characteristics of DNA hairpins containing functionalized pyrrolo-2′-deoxycytidines. Bioorganic Chemistry. 71. 294–298. 8 indexed citations
5.
Boryski, Jerzy, et al.. (2017). Dimroth Rearrangement-Old but not Outdated. Current Organic Chemistry. 21(25). 20 indexed citations
6.
Framski, Grzegorz, Marta Kujda, Jacek Stawiński, et al.. (2016). New 3′-O-aromatic acyl-5-fluoro-2′-deoxyuridine derivatives as potential anticancer agents. European Journal of Medicinal Chemistry. 115. 41–52. 11 indexed citations
7.
Baranowski, Daniel, et al.. (2016). 3′-O- and 5′-O-Propargyl Derivatives of 5-Fluoro-2′-Deoxyuridine: Synthesis, Cytotoxic Evaluation and Conformational Analysis. Nucleosides Nucleotides & Nucleic Acids. 35(4). 178–194. 6 indexed citations
8.
Framski, Grzegorz, et al.. (2016). Base-Modified Nucleosides: Etheno Derivatives. Frontiers in Chemistry. 4. 19–19. 27 indexed citations
9.
Stawiński, Jacek, Jerzy Boryski, Aleksandra Dąbrowska, et al.. (2015). Aryl H-Phosphonates 18. Synthesis, properties, and biological activity of 2′,3′-dideoxynucleoside (N-heteroaryl)phosphoramidates of increased lipophilicity. European Journal of Medicinal Chemistry. 100. 77–88. 12 indexed citations
10.
Framski, Grzegorz, et al.. (2015). Bioactive fused heterocycles: Nucleoside analogs with an additional ring. European Journal of Medicinal Chemistry. 97. 388–396. 44 indexed citations
11.
Boryski, Jerzy, Jacek Stawiński, Adam Kraszewski, et al.. (2009). Aryl nucleoside H-phosphonates. Part 16: Synthesis and anti-HIV-1 activity of di-aryl nucleoside phosphotriesters. Bioorganic & Medicinal Chemistry. 17(9). 3489–3498. 18 indexed citations
12.
Zawadzki, Paweł, et al.. (2009). A fluorescence correlation spectroscopy study of ligand interaction with cytokinin-specific binding protein from mung bean. Biological Chemistry. 391(1). 43–53. 15 indexed citations
13.
Grynkiewicz, Grzegorz, Wiesław Szeja, & Jerzy Boryski. (2009). Synthetic analogs of natural glycosides in drug discovery and development.. PubMed. 65(6). 655–76. 17 indexed citations
14.
Boryski, Jerzy, Jacek Stawiński, Adam Kraszewski, et al.. (2005). Aryl nucleoside H-phosphonates. Part 15: Synthesis, properties and, anti-HIV activity of aryl nucleoside 5′-α-hydroxyphosphonates. Bioorganic & Medicinal Chemistry. 14(6). 1924–1934. 51 indexed citations
15.
Boryski, Jerzy, et al.. (2003). Cytostatic and cytotoxic activity of synthetic genistein glycosides against human cancer cell lines. Cancer Letters. 203(1). 59–69. 67 indexed citations
16.
Boryski, Jerzy, et al.. (2003). Rearrangement Reactions of Guanosine Cyclonucleosides and Their Analogs. Nucleosides Nucleotides & Nucleic Acids. 22(5-8). 735–737. 1 indexed citations
17.
Boryski, Jerzy. (1999). Acyclonucleosides of Indazole and Their Rearrangements. Polish Journal of Chemistry. 73(6). 1019–1027. 3 indexed citations
18.
Boryski, Jerzy, et al.. (1995). Tautomerism and Regioselectivity in Ribosylation of Guanine. Nucleosides and Nucleotides. 14(3-5). 287–290. 7 indexed citations
19.
Boryski, Jerzy, Bożenna Golankiewicz, & Erik De Clercq. (1991). Synthesis and antiviral activity of 3-substituted derivatives of 3,9-dihydro-9-oxo-5H-imidazo[1,2-a]purines, tricyclic analogs of acyclovir and ganciclovir. Journal of Medicinal Chemistry. 34(8). 2380–2383. 50 indexed citations
20.
Boryski, Jerzy, Bożenna Golankiewicz, & Erik De Clercq. (1988). Synthesis and antiviral activity of novel N-substituted derivatives of acyclovir. Journal of Medicinal Chemistry. 31(7). 1351–1355. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lenka Poštová Slavětínská Breakdown of academic impact, for papers by Elmer J. Reist Breakdown of academic impact, for papers by K. Raja Reddy Breakdown of academic impact, for papers by Kazuo Sakane Breakdown of academic impact, for papers by Argyrides Argyrou Breakdown of academic impact, for papers by Tasneem A. Khwaja Breakdown of academic impact, for papers by Konrad Misiura Breakdown of academic impact, for papers by Woo‐Baeg Choi Breakdown of academic impact, for papers by Ernest J. Prisbe Breakdown of academic impact, for papers by Sheng Tang
Rankless by CCL
2026